US 11186590
Somatostatin modulators and uses thereof
granted A61KA61K47/14A61K9/0014
Quick answer
US patent 11186590 (Somatostatin modulators and uses thereof) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRINETICS PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K47/14, A61K9/0014, A61K9/0019, A61K9/0095